Saturday 17 October 2026
Export NBTX’s income statement to Excel — free account
Nanobiotix S.A. - Sponsored ADR
NBTX Healthcare Biotechnology
21.30
0.93
−4.18%
Follow NBTX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 5 | 3 | 2 | 4 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
4,617.90 | 573.24 | 1,468.06 | 741.02 | 1,617.86 | 2,557.11 | 2,115.07 | 2,115.07 | 2,115.07 | 2,115.07 |
Altman Z-Score |
3.40 | — | 0.89 | (2.71) | 0.24 | 3.05 | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(2.30) | — | (0.70) | (7.11) | (0.98) | 3.72 | (4.87) | — | — | (8.31) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | 2.44 | (4.60) | 48.02 | 1.54 | — | — | — | — |
P/Operating CF |
(19.72) | (2.45) | (6.27) | (3.16) | (6.91) | (14.07) | (14.48) | (14.48) | (14.48) | (14.48) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 5.33 | 4.27 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 5.33 | 4.27 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
4,526.00 | 537.50 | 1,167.28 | 803.15 | 1,146.44 | 1,917.58 | 2,239.44 | 2,239.44 | 2,239.44 | 2,239.44 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(5.56) | (0.94) | (1.35) | (0.75) | (1.21) | (2.22) | (3.81) | (3.81) | (3.81) | (3.81) |
EV/FCF |
(5.41) | (0.91) | (1.34) | (0.75) | (1.20) | (2.22) | (3.81) | (3.81) | (3.81) | (3.81) |
Quick Ratio |
0.95 | 0.89 | 1.53 | 1.09 | 2.38 | 6.26 | 2.45 | 3.58 | 5.57 | 3.16 |
Current Ratio |
1.09 | 1.04 | 1.75 | 1.38 | 2.53 | 6.58 | 3.22 | 3.68 | 5.68 | 3.26 |
Net Debt/EBITDA |
5.66 | 0.74 | 2.98 | 0.92 | 1.64 | 3.44 | 0.78 | 0.48 | 1.50 | 0.61 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 44.59% | 0.00% | 18.79% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.46 | 0.11 | 0.33 |
Asset Turnover |
0.49 | (0.09) | 0.48 | 0.05 | 0.02 | 0.03 | 0.05 | 0.00 | 0.02 | 0.03 |
Operating CF/Net income |
1.39 | 0.29 | 0.31 | 0.65 | 0.64 | 0.82 | 0.81 | 0.86 | 0.81 | 0.84 |
Capex/Depreciation |
(0.37) | (0.52) | (0.22) | (0.06) | (0.15) | (0.06) | (0.82) | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(0.71) | (9.13) | (1.81) | (3.37) | (67.41) | 13.77 | (9.41) | (75.89) | (406.46) | (316.12) |
| 32.53% | 201.73% | 281.84% | (3,754.04%) | (99.13%) | (97.94%) | (812.85%) | (101.46%) | (89.17%) | (65.20%) | |
| (36.24%) | (84.46%) | (52.21%) | (65.55%) | (40.66%) | (35.52%) | (98.45%) | (82.41%) | (198.42%) | (45.76%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(244.27%) | (844.36%) | (90.81%) | (264.79%) | (72.98%) | (29.35%) | (123.68%) | (89.41%) | (55.92%) | (103.82%) |
Average Days of Receivables |
23.92 | (151.11) | 9.12 | 7.72 | 514.28 | 9.01 | 1.58 | 16,840.34 | 7,093.31 | 1,177.74 |
Research and Development Expense of Revenue |
70.92% | (563.77%) | 106.05% | 683.33% | 1,147.63% | 968.54% | 1,196.82% | 17,550.86% | 6,337.18% | 1,064.28% |
Selling, General and Administrative Expense of Revenue |
62.47% | (285.45%) | 60.90% | 373.89% | 734.18% | 581.64% | 744.16% | 10,877.59% | 4,895.00% | 658.33% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
10.86% | (59.77%) | 8.90% | 66.46% | 120.93% | 116.40% | 170.01% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.21) | (1.30) | (0.06) | (0.47) | 0.13 | 0.20 | (0.10) | (0.10) | (0.10) | (0.10) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(14.36%) | (115.71%) | (45.18%) | (89.51%) | (39.45%) | (25.87%) | (27.79%) | (27.79%) | (27.79%) | (27.79%) |
Free Cash Flow Yield |
(18.11%) | (103.52%) | (59.37%) | (144.50%) | (59.01%) | (33.78%) | (27.80%) | (27.80%) | (27.80%) | (27.80%) |
Revenue per Share |
0.77 | (0.16) | 1.06 | 0.14 | 0.09 | 0.12 | 0.13 | 0.01 | 0.02 | 0.11 |
Operating CF per Share |
(0.79) | (0.45) | (0.37) | (1.12) | (1.02) | (1.29) | (2.13) | (1.13) | (1.46) | (1.26) |
Capex per Share |
(0.01) | (0.02) | (0.01) | 0.00 | (0.01) | 0.00 | (0.07) | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.80) | (0.47) | (0.38) | (1.12) | (1.03) | (1.29) | (2.21) | (1.13) | (1.46) | (1.26) |
Cash per Share |
1.25 | 1.14 | 2.21 | 1.25 | 2.86 | 5.58 | 1.82 | 1.57 | 3.25 | 1.45 |
Shareholders Equity per Share |
(2.00) | (1.50) | (0.05) | (0.82) | 0.91 | 3.30 | (0.10) | 0.61 | 3.01 | 1.18 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(2.00) | (1.50) | (0.05) | (0.82) | 0.91 | 3.30 | (0.10) | 0.61 | 3.01 | 1.18 |
Free Cash Flow |
(38.43) | (22.07) | (13.87) | (39.19) | (35.62) | (31.58) | (47.73) | (29.87) | (25.47) | (19.32) |
Working Capital |
5.93 | 2.74 | 40.55 | 15.20 | 66.51 | 121.32 | 35.59 | 35.69 | 52.72 | 19.63 |
Capital Expenditures |
(0.62) | (0.92) | (0.36) | (0.10) | (0.28) | (0.12) | (1.62) | (0.58) | (1.76) | (0.42) |
Net Current Asset Value |
(101.25) | (77.54) | (9.09) | (36.30) | 21.39 | 70.46 | (13.42) | 12.30 | 47.67 | 14.62 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | (0.12) | 0.01 | 0.02 | 0.09 | 0.04 | 0.57 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.33 | 0.29 | 0.24 | 0.21 | 0.19 | 0.21 | 0.19 | 0.21 | 0.14 | 0.20 |
Cash ROIC |
107.04% | 127.76% | (17.45%) | (259.34%) | (27.19%) | (14.58%) | (128.41%) | (36.71%) | (22.12%) | (41.83%) |
Accounts Receivable Turnover |
13.08 | (3.70) | 72.17 | 2.23 | 1.40 | 69.06 | 0.92 | 0.02 | 0.05 | 0.29 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | — | — | — | — | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,432.23 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | — | — | 0.00 | — |
Average Receivables |
2.82 | 2.10 | 0.54 | 2.26 | 2.24 | 0.04 | 3.08 | 6.03 | 5.60 | 5.60 |
Average Payables |
16.00 | 20.71 | 14.94 | 8.90 | 7.89 | 8.41 | 8.09 | 6.84 | 5.40 | 5.40 |
Average Assets |
74.81 | 87.29 | 82.30 | 91.69 | 136.75 | 108.03 | 57.92 | 42.32 | 15.87 | 50.33 |
Average Common Equity |
(83.34) | (36.55) | (15.25) | 1.60 | 56.10 | 39.18 | 7.02 | 34.38 | 35.32 | 35.32 |
Columns are period end dates · fundamentals updated 28 Sep 2026